|EMiC®2 filter for the removal of middle molecules|
|Enhanced Middle Molecule Clearance|
|Cut-off at around ~ 40 kDa|
|Advanced hollow fiber undulation|
|Steep sieving coefficient curve closely mimics the glomerular basement membrane|
|Substantially stable albumin levels|
|High efficacy also at low blood flows|
The Ultraflux® filters contain a Fresenius Polysulfone® membrane specifically developed for continuous renal replacement therapy. With this membrane, substances with a molecular weight of up to approximately 30kD can be eliminated. While plasma proteins like albumin, other large molecules and cellular blood constituents are retained. The filtration characteristics of this membrane come close to the natural human kidney’s function.
Due to their high mechanical stability and excellent filter lifetimes, the Ultraflux® filters AV paed, AV 400S, AV 600S, AV 1000S are applicable for use in all continuous renal replacement treatments.
|Steam-sterilized dry plasma filter with two-layer membrane structure and modelled membrane topology|
|Dry delivery enables simplified set-up with a shortening of the rinsing procedure|
|Dedicated pores allow free passage of protein components such as immunoglobulins, lipoproteins and also other big molecules with molecular weights even those exceeding two million Dalton|
|The membrane’s blood contact surface has a coarse-meshed topology that prevents blood cells from blocking fine pores; a stable filtration process at low TMP with excellent sieving coefficient is enabled|
|Passage of blood cells through the membrane is prevented|
|The surface layer inside of the capillary is surrounded and stabilized by a second homogeneous, fine-pored layer|
|Fresenius Polysulfone® membrane offers excellent biocompatibility|